Psychiatric-Pharmaceutical Push To Profit From COVID-19 Pandemic Ignores Individuals’ Resilience In Times Of Crisis

Note:  The rising number of COVID-19 cases nationwide has generated alarming and self-serving predictions from the psychiatric industry about a potentially devastating mental health crisis in the making, along with a wave of urgent calls for huge increases in government funding for mental health treatment.  In response, we are republishing a May 2020 article from Citizens Commission on Human Rights International that reviews how wrong the predictions of mental health crises were in earlier disasters and how research has found that in times of crises, the individual’s own resilience has often proven to be the best “treatment” – and with no risk of the harmful and even life-threatening side effects of the psychiatric drugs used in mental health treatment.  [Warning: No one should stop taking any psychiatric drug unless under the supervision of a competent medical doctor.]

Some Media are Starting to Report How Resilience (Not Mind-Altering Psychotropic Drugs) is Better at Facing COVID-19 Restrictions

Hands on window
CCHR wants people better informed about the psychiatric-pharmaceutical agenda to use normal reactions to virus restrictions to push harmful psychiatric labels and drugs. The sources of predictions about “mental health epidemics” often have conflicts of interests with manufacturers of psychotropic drugs.

By Jan Eastgate
President CCHR International
The Mental Health Industry Watchdog
May 29, 2020

Throughout April-May 2020, Citizens Commission on Human Rights International has researched and provided information about the psychiatric-pharmaceutical industry using COVID-19 to scare people into believing that their mental health may be irreparably damaged. Antidepressant and anti-anxiety drugs, that carry a heinous list of side effects, have been promoted, taking advantage of people’s understandable vulnerabilities—their normal reactions to abnormal times. Psychiatric drugs are already being tested to be repurposed to treat COVID-19, despite their own potential life-threatening risks.

However, CCHR’s research has also found that people’s resilience in times of disasters, including wars and terrorism, has often been the people’s best “treatment.” It was, therefore, a nice change to see mainstream media report and further substantiate this.

For example, on May 25, 2020, The Australian reported that rather than a “mental health epidemic” as a result of COVID, “history suggests we often rebound from mass trauma events.” In the late 1930s, “as Britain braced itself for a looming war and predicted mass civilian casualties from German bombing,” a committee of psychiatrists predicted that the bombs would cause three times more mental injuries than physical. Several large psychiatric hospitals were built outside London to deal with the mass trauma.

But despite 57 sequential nights of bombings, 41,000 Londoners killed and two million homes destroyed, every one of the predictions about how Londoners would react turned out to be wrong. In fact, the psychiatric hospitals remained empty and were repurposed for the physically wounded.

Something similar occurred following the 9/11 attacks in New York in 2001. It was predicted that one in four New Yorkers would suffer PTSD and 9,000 counselors were dispatched across the U.S. to be prepared to deliver. But the tents established to deliver such services remained largely empty, and only half of the $200 million set aside for mental health help was spent.[1]

Richard Bryant, a professor of psychology at the University of New South Wales, who studied the impact of Australia’s devastating Black Saturday bushfires in 2009 said that 82% of people remained resilient.[2] Approximately 400 fires were recorded across Victoria; 173 people tragically lost their lives from the series of fires in 2009 and 414 were injured.[3] But as one study Bryant was involved in found, “Several years following the Black Saturday bushfires the majority of affected people demonstrated resilience without indications of psychological distress.” Only a minority required services for persistent problems.

Responding to recent mental health experts expecting a “tsunami of mental health disorders” from COVID, Bryant stated: “We know that time and time again over every disaster, including previous pandemics, most people will end up being resilient.” [4]

One of those doomsday mental health “experts” was Dr. Ian Hickie who, writing in The Guardian in the UK, claimed “the potential mental health and suicide impacts resulting from the massive economic and social dislocation caused by Covid-19 are front and center internationally.” He further reported a “predicted 25-50% increase in suicides over the next five years” according to his Brain and Mind Centre at the University of Sydney, of which he is co-director of health and policy. Hickie reported that the Australian health minister, Greg Hunt, made “Covid-19-precipitated mental ill health the same status as physical ill health.” The government has announced AUS $48.1m (U.S.$32 million) in additional funding for mental health.

Hickie, along with his cohort, psychiatrist Patrick McGorry, are the co-founders of Australia’s national headspace: Youth Mental Health Centers in Australia which treat 12-25-year olds. Researchers have criticized the centers for being used as “’clinical laboratories’ for applied research.”[5] McGorry and Hickie were part of a joint statement on COVID-19 issued on May 7, that predicted “increases in youth suicide and a surge in demand for specialist mental health services,” and the telltale “calling for long-term modelling and investment in mental health to guide critical decision making in social, economic, and health policy to help Australia transition out of the coronavirus pandemic.” That “modeling” is based on one developed by the Brain and Mind Centre, and Australia’s The National Health and Medical Research Council (NHMRC) Centre for Research Excellence on prevention of youth suicide (YOUTHe), in which McGorry’s research group Orygen and the University of Melbourne are partnering. McGorry is the Professor of Youth Mental Health at the university.

It’s easy to “predict” that from such demands that this could lead to increased antidepressant and other psychotropic drug prescriptions, with individuals uninformed that the drugs can actually induce suicide prescribed to “prevent”—and that those suicides will be attributed not to the drugs but to “COVID-19 related” issues.

Hickie has served on the professional advisory boards convened by the drug industry in relation to specific antidepressants made by Bristol-Myers Squibb (BMS) and Eli Lilly and has led projects funded in part by BMS, Pfizer, Eli Lilly, Wyeth and Servier.[6] He has served on advisory boards convened by the pharmaceutical industry in relation to three specific antidepressants.[7]

McGorry is renowned for his debunked dangerous theory that pre-drugging adolescents with antipsychotics can prevent psychosis.[8] Mental health specialists told Australia’s Sunday Age that the focus on early intervention for adolescents and young adults had been “massively oversold” by the “McGorry lobbying machine.” “It’s extremely worrying that the government is listening to professional lobbyists who have a massive personal investment in the programs they’re recommending – and they are undoubtedly overstating the evidence. There’s a massive conflict of interest there,” said Professor David Castle from Melbourne’s St. Vincent’s Hospitals, referring to both Hickie and McGorry.[9]

McGorry has had financial ties to the drug companies, Janssen-Cilag, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Pfizer and Novartis. He has also received honoraria for consulting and teaching from Roche, Lundbeck, and Astra Zeneca. His Orygen Centre operates four of the 27 headspace centers in Victoria.   Orygen has also been funded by drug companies Eli Lilly, AstraZeneca, Janssen-Cilag and Bristol-Myers Squibb.[10]

In the U.S., the American Psychiatric Association (APA) has purported that those put in isolation are “more likely to develop PTSD or increase substance use;” that the required excessive cleaning of hands could lead to compulsions;[11] and that almost 60% feel that the virus is having a serious impact on their day-to-day lives.[12] APA posted on its website that an “anxiety pandemic” is following fast on COVID’s heels.[13]

Perpetuating this, on May 21, the American Psychological Association released the results of a 10-point subjective survey of parents with children under 18, asserting that 46% rated their average stress level regarding the pandemic as 8, 9 or 10 on a 10-point scale. An article quoted Charles B. Nemeroff, professor and chair of the department of psychiatry at Dell Medical School at the University of Texas at Austin and president-elect of the Anxiety and Depression Association of America (ADAA). He stated: “This kind of chronic stress brings about, for all those people who have never had anxiety before, it sort of overwhelms them.” Pharmaceutical companies, including AstraZeneca, Eli Lilly, Forest Laboratories, GlaxoSmithKline, Pfizer, Solvay Pharmaceuticals, and Wyeth fund ADAA.[14]

Nemeroff came under federal investigation for his failure to declare $1 million he took from pharmaceutical companies. He’d taken the money while conducting supposedly unbiased research for the National Institutes of Health on drugs made by the companies he was receiving money from. A front-page report by The New York Times in October 2008 said that congressional investigators found Nemeroff had received $2.8 million in consulting deals with drug makers over seven years and failed to report at least $1.2 million of that to Emery University.[15]

The Wall Street Journal reported at least some of the warnings about the drugs: “Because benzodiazepines can reduce the body’s drive to breathe, overdoses can be deadly” and the drugs “can be difficult to stop, too. Withdrawal symptoms can include a surge in anxiety, tremors and, in some cases, seizures. The medications can be particularly dangerous for older adults: In seniors, their use is associated with falls and cognitive problems.” Overdose deaths involving benzodiazepines more than quadrupled between 1999 and 2013, according to a study published in 2016 in the American Journal of Public Health.[16]

CCHR’s online psychiatric drugs side effects searchable database is an excellent resource for finding free information about adverse effects of psychotropic drugs and the many drug regulatory agency warnings about them.

CCHR is fully aware of how the country’s challenging times (with its own staff part of the stay-at-home restrictions) and how, generally at a societal level, it can impact mental and physical health. But APA and other mental disorder groups making claims that high percentages of people will be anxious, depressed or have PTSD (based largely on surveys of a small number of people, and often with a Public Relations firm spin) is self-serving to rake in future profits. CCHR is researching more articles that convey how individuals’ innate resilience, including that which comes with a recovered economy and job safety, is most likely to be a winning “medicine.”

References:

[1] “Blitz Spirit: Fortunately for the COVID-19 generation, history suggests we often rebound from mass trauma events,” The Australian, 25 May 2020,  https://www.theaustralian.com.au/inquirer/covid-health-crisis-trauma-could-be-overstated/news-story/a6146f9449f3748d1e21c2d1f11ad310
[2] Ibid.
[3] https://www.nma.gov.au/defining-moments/resources/black-saturday-bushfires; https://knowledge.aidr.org.au/resources/bushfire-black-saturday-victoria-2009/
[4] Op. cit., The Australian, 25 May 2020
[5] https://www.cchrint.org/2015/04/27/drugging-kids-patrick-mcgorry/
[6] https://www.cchrint.org/2017/03/15/patrick-mcgorry-plans-to-dope-12yearolds-with-cannabis/
[7] https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1751-7893.2012.00366.x
[8] https://www.cchrint.org/2017/03/15/patrick-mcgorry-plans-to-dope-12yearolds-with-cannabis/
[9] https://www.smh.com.au/national/mcgorry-accused-of-conflict-of-interest-20110806-1igxd.html
[10] https://www.pc.gov.au/__data/assets/pdf_file/0019/240814/sub290-mental-health.pdf
[11] https://www.psychiatrictimes.com/sites/default/files/legacy/mm/digital/media/03Mar_PTMorganstein_Coronavirus_PDF_V2.pdf; https://www.psychiatrictimes.com/psychiatrists-beware-impact-coronavirus-pandemics-mental-health
[12] https://www.jnj.com/personal-stories/covid-19-taught-doctor-resilience-and-hope
[13] https://www.psychiatry.org/patients-families/anxiety-disorders
[14] https://www.cchrint.org/issues/psycho-pharmaceutical-front-groups/adaa/
[15] https://www.nytimes.com/2008/10/04/health/policy/04drug.html
[16] “More People Are Taking Drugs for Anxiety and Insomnia, and Doctors Are Worried,” Wall Street Journal, 25 May 2020, https://www.wsj.com/articles/more-people-are-taking-drugs-for-anxiety-and-insomnia-and-doctors-are-worried-11590411600

Psychiatric Industry Aims To Profit From Racism, Targets African Americans

While many Americans see the recent racial tension in this country as an opportunity to address the issue of racial injustice, the psychiatric-pharmaceutical industry sees it as an opportunity to expand their reach – very profitably – into the African American community. 

Psychiatrists, psychologists, and mental health groups, many funded by pharmaceutical companies, had already been arbitrarily asserting that African Americans are 20% more likely to experience serious mental health problems, and less likely to identify their own mental health problems, than the general population.

Now psychiatric practitioners are trying to create a higher level of urgency.  The American Psychological Association has announced that “we are living in a racism pandemic.” 

Psychiatrists and psychologists are labeling the very real pain experienced from racism as a psychiatric disorder – post-traumatic stress disorder (PTSD) – for which a standard treatment is antidepressants.  These are drugs that carry the risk of serious and debilitating physical and mental side effects, including emotional blunting, worsening depression, sexual problems, birth defects, anxiety, hallucinations, agitation, violence, and suicidal thoughts and actions.  Patrick D. Hahn, Affiliate Professor of Biology, Loyola University Maryland warns, “The link between antidepressants and violence, including suicide and homicide, is well established.”

American psychological and psychiatric associations have already developed guidelines on how to “treat” racism – guidelines that ensure that Black Americans are informed about psychiatric drugs as treatment. 

Psychiatrists and psychologists have a long history of re-defining people’s normal responses to bad situations as “mental disorders” requiring their “treatment.”  But history shows that Blacks have been especially targeted for “treatment,” and so have good reason to beware of practitioners in the psychiatric industry.

Professors Herb Kutchins and Stuart Kirk, co-authors of Making Us Crazy: The Psychiatric Bible and the Creation of Mental Disorders, state:  “Defenders of slavery, proponents of racial segregation…have consistently attempted to justify oppression by inventing new mental illnesses and by reporting higher rates of abnormality among African Americans or other minorities.”

They further warn: “Innovations in diagnostic and treatment techniques are often proposed by those who claim to be committed to helping African Americans and other minority groups, but these innovations often perpetuate and increase racist thinking and lead to solutions that intensify persecution.“

For generations, psychiatrists and psychologists have been prime instigators of “scientific racism,” using pseudo-science to invent “racial diseases,” promote theories to “justify” segregation and racial population control, and subject Blacks to depraved “treatments” and barbaric psychiatric experiments.  Here are some key facts from that sordid history.

  • Though Dr. Benjamin Rush, the “Father of American Psychiatry, claimed he was anti-slavery in the late 1700s, in fact he purchased a child slave, whom he later freed only after being paid what he considered adequate compensation.  More importantly, he created a medical model of racism whose legacy is still felt today.  He claimed Blacks suffered from a disease called “negritude,” supposedly a form of leprosy.  Like lepers, he said, Blacks needed to be segregated to prevent them from “infecting” others.
  • Though Dr. Benjamin Rush, the “Father of American Psychiatry, claimed he was anti-slavery in the late 1700s, in fact he purchased a child slave, whom he later freed only after being paid what he considered adequate compensation.  More importantly, he created a medical model of racism whose legacy is still felt today.  He claimed Blacks suffered from a disease called “negritude,” supposedly a form of leprosy.  Like lepers, he said, Blacks needed to be segregated to prevent them from “infecting” others.

Psychiatrists and Psychologists Create Eugenics to “Justify” Racism

  • In 1883, English psychologist Francis Galton created the term “eugenics” (from the Greek word eugenes, meaning “good stock”) to encourage “better” human breeding and discourage those with “less desirable” traits from having children.  Eugenics is based on the belief that some humans are inferior to others.  Galton considered Africans inferior, writing: “These savages court [ask for] slavery.” 

The ideas of eugenics and “racial purification” would spread globally and would be used later “justify” many human rights abuses and atrocities, including the Nazi’s extermination of “inferior races” in the Holocaust, South Africa’s apartheid, Planned Parenthood founder Margaret Sanger’s push to exterminate the Black population through sterilization, and the Ku Klux Klan’s activities to eliminate non-whites – all to “protect” the white race, and all with their roots in eugenics.  

Psychiatrists and psychologists in the American mental health movement adopted and promoted the pseudo-science of eugenics in the U.S., spreading the racist idea of Black inferiority. 

A review of the history of the field of psychology revealed that in every decade from 1900-1970, there was a prominent American psychologist who was a proponent of the theory of the genetic inferiority of Blacks.  Many of these racist psychologists became presidents of the American Psychological Association.

  • The resurgence of the Ku Klux Klan in the U.S. in the early 1900s occurred at a time when psychiatry’s eugenics-based racism was being broadly promoted in America, fueling the KKK’s mission of white supremacy.  In 1923, Hiram Wesley Evans, Grand Wizard of the KKK, referenced eugenics leaders in his speech given on “Klan Day.”

Psychiatry’s Embrace of Eugenics Leads to Racist Views of Blacks’ Intelligence 

  • In the 1920s, American eugenicists claimed that the IQ of Blacks was determined by the amount of “white blood” in them.  Interracial marriages were said to lower the IQ of whites.
  • In the 1950s, U.S. psychiatrist J.C. Carothers published a study with the World Health Organization, stating “that in many ways the African resembles a European 8- or 9-year old child in his reaction to the environment.”  He compared the African to a “leucotomized European.”  (“Leucotomy” is another word for “lobotomy,” psychiatry’s barbaric surgical procedure of cutting nerve connections in the front part of the brain to try to alter behavior.)
  • Psychiatry and psychology have a history of using biased intelligence testing to legitimize racism, appearing to “prove” that African Americans have lower IQs.  In the 1950s, Stanford University psychologist Lewis Terman, an “expert” on IQ testing, used biased IQ testing extensively, then asserted that non-whites could never be educated and that Blacks should never be allowed to have children.
  • As recently as 1994, psychologist Richard Herrnstein co-authored the book, The Bell Curve, in whichhe claimed that Blacks performed worse on intelligence tests than Whites and are“genetically disabled.”In an argument similar to those made by earlier  proponents of eugenics and “racial purity,” Herrnsteinadvocated selective breeding to limit the black population.

Psychiatry Targets Blacks for Experimentation and Barbaric “Treatments” in the U.S.

  • Psychiatric “treatment” of minorities in the U.S. has included some of the most barbaric experiments ever carried out in the name of “scientific” research.

In the 1940s, U.S. psychiatrist Walter Freeman believed that Blacks, especially Black women, were among the best candidates for a lobotomy because families were more likely to give their relatives who survived the lobotomy devoted post-operative care.  (A lobotomy is psychiatry’s barbaric surgical procedure of cutting nerve connections in the front part of the brain to try to alter behavior.)  In 1951, Freeman lobotomized Black patients in an experiment at the Veterans Administration hospital in Tuskegee, Alabama, describing the procedure as “a surgically induced childhood.”

  • In the 1950s in New Orleans, black prisoners were used for psychosurgery experiments that implanted electrodes into their brains by psychiatrist Robert Heath from Tulane University and psychiatrist Harry Bailey from Australia.  Bailey later boasted about the reason they had chosen Black test subjects, saying it was “cheaper to use [Blacks*] than cats because they were everywhere and cheap experimental animals.” [*Bailey’s racial slur is omitted here]
  • Psychiatrist Robert Heath also conducted secret drug experiments, funded by the Central Intelligence Agency (CIA), using LSD and a drug called bulbocapnine, which in certain doses produces severe stupor.  He experimented on Black prisoners at the Louisiana State Penitentiary to see if the drug would cause “loss of speech, loss of sensitivity to pain, loss of memory, [and] loss of will power…”
  • African Americans were targeted for brutal drug experiments at the National Institute of Mental Health (NIMH), the country’s top mental-health research facility.  In the mid-1950s, drug-addicted Blacks were used in an experiment with LSD that kept many hallucinating for 77 consecutive days.  In the 1960s, NIMH again used Black men as test subjects for an experimental hallucinogen, the chemical warfare drug BZ, which was many times more powerful than LSD.

Psychiatrists Invent Racist Diagnosis and Treatment for Blacks in Civil Rights Era

  • In the 1960s, psychiatrists invented the term “protest psychosis” to stereotype Blacks participating in the Civil Rights movement as aggressive.  Claims were made that joining in protests was a symptom of “schizophrenia.”  Ads for powerful antipsychotic drugs in psychiatric journals at the time used images of angry Black men or African tribal symbols to influence the prescribing of antipsychotic drugs to Blacks.  Today, African Americans are still disproportionately prescribed antipsychotic drugs.
  • In the 1970s, following riots in Watts, a predominantly black section of Los Angeles, the National Institute of Mental Health supported a “Violence Initiative” by psychiatrist Louis Jolyon West, the head of UCLA’spsychiatrydepartmentand Neuropsychiatric Institute, which was a proposal to treat young black urban male offenders with psychosurgery (cutting into the brain to disable parts of it)and chemical castration (using drugs to reduce the drive or ability for sexual activity).  Protests led by CCHR and others caused government funding for this project to be cut.
  • A second “Violence Initiative” supported by the National Institute of Mental Health gave psychiatric drugs to Blacks, including children as young as five, supposedly to research whether African-Americans had a violence gene that could be controlled by psychiatric drugs.
  • Racism towards African Americans continued for decades at the National Institute of Mental Health.  In 1992, psychiatrist Frederick Goodwin, executive director of the NIMH, compared Black youth living in inner cities to “hyper-aggressive” and “hyper-sexual” monkeys in a jungle. 

Today, a hidden eugenics agenda is still evident in the institutional racism of the psychiatric industry.  African Americans are disproportionately diagnosed with mental illness and disproportionately admitted to psychiatric and behavioral facilities.

They are disproportionately diagnosed as having a psychotic disorder, especially schizophrenia, and they are disproportionately prescribed antipsychotic drugs.  Black men, in particular, are more likely to be prescribed excessive doses of these psychiatric drugs. 

“Whipping the devil out of them” has been replaced with psychosurgery, electroshock, and psychiatric drugs.

CCHR International’s Task Force Against Racism & Modern Day Eugenics

In response to the psychiatric industry’s plan to sell psychiatric drugs and mental health treatment as the answer to racism, Citizens Commission on Human Rights International and Rev. Fred Shaw, Jr. launched the Task Force Against Psychiatric Racism and Modern Day Eugenics.  Its mission is to investigate and combat institutional racism and inform and empower the African American community with the facts about racism and eugenics masked as mental health care.

Rev. Shaw is an ordained minister with over 25 years of experience as a human rights advocate.  He served as a Los Angeles County Deputy Sheriff and is currently the Executive Director of the Inglewood-South Bay chapter of the NAACP.  He has obtained three NAACP national resolutions against the forced drugging and electroshocking of children and teens, and he is a past recipient of the Congressional Black Caucus Foundation award for his NAACP leadership and dedication in protecting children against psychiatric labeling and drugging.  He is also a CCHR spokesperson.

As a human rights organization and mental health industry watchdog, CCHR has exposed and campaigned against racism and racial abuse in the mental health system since our inception in 1969.  CCHR has worked with the NAACP since 2003 in exposing the stigmatizing labeling and drugging of African American children and, with Rev. Shaw, in obtaining the three national NAACP resolutions.

The entrenched legacy of eugenics in the mental health industry has permeated all sectors of society, paving the way for racial discrimination and abuse.  CCHR is dedicated to bringing to light the truth about how psychiatry and psychology are the instigators and peddlers of racism, not the help for it.

For more information, contact CCHR Colorado at (303) 789-5225.

Colorado Medicaid Doctor Prescribes a Whopping $1.1 Million of Antipsychotic Drugs in Just 2008 and 2009 Alone

Colorado’s top Medicaid prescriber of drugs at the center of a U.S. senator’s probe into fraud, waste and abuse in the Medicaid system billed nearly $1.1 million in 2008 and 2009 for 1,304 prescriptions written on four expensive antipsychotic drugs, according to data obtained by the Citizens Commission on Human Rights of Colorado.

The high-prescribing doctor was identified only by the prescriber identifier number 1093800559 in data compiled by the Colorado Department of Health Care Policy & Financing (CDHCPF) in response to a request from U.S. Senator Charles Grassley of Iowa, ranking Republican on the Senate Finance Committee, which oversees Medicaid and Medicare.

In April the senator requested 2008 and 2009 data from all 50 state Medicaid agencies on the top 10 Medicaid prescribers for each of six antipsychotic and two narcotic drugs, citing his concern they are being overprescribed at great cost to the publicly-funded Medicaid and Medicare programs.  Following his review of the data, Grassley called for a federal investigation.

Collectively Colorado’s top 10 Medicaid prescribers of the six antipsychotic drugs in question billed Medicaid a total of $8,172,649 over the two-year period, billing $3,045,015 in 2008 and $5,127,634 in 2009 for a 68 percent increase.

Colorado taxpayers have good reason to be concerned not only about the mushrooming cost of expensive antipsychotic drugs prescribed by Medicaid psychiatrists, but also the medical costs of the physical damage these drugs can cause to the Medicaid patients taking them.

The ages of the patients for whom the prescriptions were written were not part of the released data, so it is not known whether the huge jump in prescriptions in Colorado reflects the growing nationwide trend of putting children on antipsychotics, especially poor children.  A Rutgers University study last year found that children from low-income families, like those on Medicaid, were four times as likely as the privately insured to be put on antipsychotic drugs.

Drug studies of newer antipsychotics have found they can cause serious side effects in children, including diabetes, obesity, elevated cholesterol, seizures and strokes.

According to a recent article in The New York Times, “a marketing juggernaut…has made antipsychotics the nation’s top-selling class of drugs by revenue, $14.6 billion last year, with prominent promotions aimed at children.”

Because none of Colorado’s top Medicaid antipsychotic prescribers is identified by name in the CDHCPF data, it is not possible to track any financial ties they might have with the pharmaceutical companies that make these drugs, which could lead to a higher use of the drugs and a higher cost to the Medicaid program without benefiting patients.

Recently enacted national health care reform will require pharmaceutical companies to disclose payments to doctors beginning in 2013.  In the meantime Eli Lilly & Co. and Pfizer, makers of two of the antipsychotic drugs targeted by Sen. Grassley, must already disclose their payments to doctors as part of agreements reached with the U.S. Department of Justice.

With Colorado already facing what the governor’s office estimates as  a $262 million general-fund shortfall for the current 2010-11 budget and facing another $1 billion shortfall in the 2011-12 budget year, details of the number and cost of prescriptions for antipsychotic and other psychiatric in the publicly-funded Medicaid program over the past 10 years should be made public, with a special focus on the increase in the number and cost of prescriptions written on antipsychotics for children.

If you or someone you know has been harmed by taking antipsychotic drugs and you want to talk about it, we want to talk to you.  Email us or call 303-789-5225. All inquiries and communication will be handled in strictest confidence. We will take action.